The 2ndsurvey | ||||||
---|---|---|---|---|---|---|
COMBINED EXPOSURE | n | Asthma, n (%) | Asthma, n (%) | Asthma OR1 | Asthma symptoms, n (%) | Asthma symptoms (OR)1 |
Total exposure2 C = 30 | 1st | 298 | 72(24.2%) | 1.00 | 41(13.8%) | 1.00 |
2nd | 298 | 68(22.8%) | 0.90 (0.61-1.35) | 32(10.8%) | 0.70(0.41-1.18) | |
3rd | 297 | 59(19.9%) | 0.76 (0.51-1.15) | 43(14.5%) | 1.09(0.67-1.77) | |
4th | 298 | 65(21.8%) | 0.87 (0.58-1.31) | 41(13.8%) | 1.09(0.66-1.79) | |
5th | 297 | 70(23.6%) | 0.96 (0.64-1.44) | 48(16.2%) | 1.28(0.79-2.08) | |
Total exposure2 C = 300 | 1st | 298 | 67(22.5%) | 1.00 | 35(11.8%) | 1.00 |
2nd | 298 | 67/22.5%) | 1.02 (0.68-1.53) | 35(11.8%) | 1.06(0.63-1.79) | |
3rd | 297 | 69(23.2%) | 1.00 (0.66-1.50) | 48(16.2%) | 1.50(0.91-2.48) | |
4th | 298 | 65(21.8%) | 0.88 (0.58-1.34) | 45(15.2%) | 1.33(0.79-2.21) | |
5th | 297 | 66(22.2%) | 0.88 (0.58-1.33) | 42(14.1%) | 1.18(0.71-1.99) | |
Residential + workplace Address2 | 1st | 298 | 73(24.5%) | 1.00 | 41(13.8%) | 1.00 |
2nd | 298 | 69(23.2%) | 0.91 (0.61-1.35) | 36(12.1%) | 0.89(0.53-1.47) | |
3rd | 297 | 54(18.2%) | 0.64 (0.42-0.97) | 36(12.2%) | 0.87(0.52-1.44) | |
4th | 298 | 69(23.2%) | 0.98 (0.66-1.46) | 46(15.5%) | 1.31(0.81-2.12) | |
5th | 297 | 69(23.2%) | 0.94 (0.63-1.41) | 46(15.5%) | 1.27(0.78-2.07) | |
Workplace Address | 1st | 298 | 74(24.8%) | 1.00 | 40(13.5%) | 1.00 |
2nd | 298 | 64(21.5%) | 0.81 (0.54-1.22) | 41(13.8%) | 1.12(0.68-1.85) | |
3rd | 297 | 66(22.2%) | 0.87 (0.58-1.31) | 41(13.8%) | 1.11(0.67-1.85) | |
4th | 298 | 67/22.5%) | 0.92 (0.62-1.37) | 40(13.5%) | 1.14(0.70-1.88) | |
5th | 297 | 63(21.2%) | 0.77 (0.51-1.16) | 43(14.6%) | 1.19(0.72-1.96) | |
Residential Address | 1st | 298 | 71(23.8%) | 1.00 | 41(13.8%) | 1.00 |
2nd | 298 | 70(23.5%) | 0.90 (0.60-1.34) | 35(11.8%) | 0.80(0.48-1.33) | |
3rd | 297 | 58(19.5%) | 0.78 (0.52-1.18) | 41(13.9%) | 1.08(0.66-1.75) | |
4th | 298 | 66(22.1%) | 0.91 (0.60-1.36) | 40(13.4%) | 1.09(0.66-1.80) | |
5th | 297 | 69(23.2%) | 0.96 (0.64-1.44) | 48(16.2%) | 1.31(0.81-2.13) |